Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events
['Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events', 130, 'Hong Kong', 'Dapagliflozin Effect on Cardiovascular Events A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients With Type 2 Diabetes']